Does urinary stone composition and morphology help for prediction of primary hyperparathyroidism?

Nephrology Dialysis Transplantation

Volumn 26, Issue 2, 2011, Pages 565-572

  Bouzidi, Hassan ^a,b   De Brauwere, David ^b   Daudon, Michel ^b  

^a Hôpital universitaire Tahar Sfar   (Tunisia)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

brushite; calcium phosphate; idiopathic hypercalciuria; nephrolithiasis; primary hyperparathyroidism; stone morphology

Indexed keywords

CALCIUM OXALATE; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; CARBAPATITE; CARBOXYLIC ACID SALT; UNCLASSIFIED DRUG; WEDDELLITE; WHEWELLITE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; IDIOPATHIC HYPERCALCIURIA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; UROLITHIASIS;

ADULT; APATITES; CALCIUM OXALATE; CALCIUM PHOSPHATES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; URINARY CALCULI;

EID: 78651308286     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq433     Document Type: Article

References (39)

1. Silverberg SJ, Shane E, Jacobs TB et al. Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 1990; 89: 327-334
2. Adami S, Maracocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002; 17: N18-N23
3. Bilezikian JP, Silverberg SJ. Clinical spectrum of primary hyperparathyroidism. Rev Endocr Metab Disord 2000; 1: 237-245
4. Kollars J, Zarroug AE, Heeden JVet al. Primary hyperparathyroidism in pediatric patients. Pediatrics 2005; 115: 974-980
5. Stenstrom G, Heedman PA. Clinical findings in patients with hypercalcaemia. A final investigation based on biochemical screening. Acta Med Scand 1974; 195: 473-477
6. Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet 1980; 1: 1317-1320
7. Wermers RA, Khosla S, Atkinson EJ et al. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 1997; 126: 433-440
8. Fraser WD. Hyperparathyroidism. Lancet 2009; 74: 145-158
9. el-Reshaid K, Mughal H, Kapoor M. Epidemiological profile, mineral metabolic pattern and crystallographic analysis of urolithiasis in Kuwait. Eur J Epidemiol 1997;13:229-234
10. Amaro CR, Goldberg J, Amaro JL et al. Metabolic assessment in patients with urinary lithiasis. Int Braz J Urol 2005; 31: 29-33
11. Pak CYC, Poindexter JR, Adams-Huet B et al. Predictive value of stone composition in the detection of metabolic abnormalities. Am J Med 2003; 115: 26-32
12. Parks JH, Coe FL, Evan AP et al. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int 2009; 103: 670-678
13. Fuss M, Pepersack T, Corvilain J et al. Infrequency of primary hyperparathyroidism in renal stone formers. BJU 1988; 62: 4-6
14. Suh JM, Cronan JJ, Monchik JM. Primary hyperparathyroidism: is there an increased prevalence of renal stone disease? Am J Roentgenol 2008; 191: 908-911
15. Daudon M, Bader CA, Jungers P. Urinary calculi: review of classification methods and correlations with etiology. Scan Microsc 1993; 7: 1081-1106
16. Estépa L, Daudon M. Contribution of Fourier transform infrared spectroscopy to the identification of urinary stones and kidney crystal deposits. Biospectroscopy 1997; 3: 347-369 (Pubitemid 127781310)
17. Yoshida O, Okada Y. Epidemiology of urolithiasis in Japan: a chronological and geographical study. Urol Int 1990; 45: 104-111 (Pubitemid 20062605)
18. Stamatelou KK, Francis ME, Jones CA et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003; 63: 1817-1823
19. Daudon M, Doré JC, Jungers P et al. Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 2004; 32: 241-247
20. Thomas WC Jr. Urinary calculi in hypercalcemic states. Endocrinol Metab Clin N Am 1990; 19: 839-849
21. Odvina CV, Sakhaee K, Heller HJ et al. Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urol Res 2007; 35: 123-128
22. Pak CY, Nicar MJ, Peterson R et al. A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism. J Clin Endocrinol Metab 1981; 53: 536-542
23. Berger AD, Wu W, Eisner BH et al. Patients with primary hyperparathyroidism- why do some form stones? J Urol 2009; 181: 2141-2145
24. Mollerup CL, Vestergaard P, Frojaer VG et al. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ 2002; 325: 1-5
25. Daudon M, Réveillaud RJ. Whewellite et weddellite: vers des étiopathogénies différentes. Intérêt du typage morphologique des calculs. Néphrologie 1984; 5: 195-201
26. Maurice-Estepa L, Levillain P, Lacour B et al. Crystalline phase differentiation in urinary calcium phosphate and magnesium phosphate calculi. Scand J Urol Nephrol 1999; 33: 299-305
27. Kohri K, Kodama M, Umekawa T et al. Calcium oxalate crystals formation in patients with hyperparathyroidism and related metabolic disturbances. Bone Miner 1990; 8: 59-67
28. Evan AP, Lingeman JE, Coe FL et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 2003; 111: 607-616
29. Matlaga BR, Coe FL, Evan AP et al. The role of Randall's plaques in the pathogenesis of calcium stones. J Urol 2007; 177: 31-38
30. Daudon M, Traxer O, Jungers P et al. Stone morphology suggestive of Randall's plaque. In: AP Evan, JE Lingeman, JC Williams (eds). Renal Stone Disease. NY, USA Melville: Am Instit Phys Conf Proc 2007; 900: 26-34
31. Low RK, Stoller ML. Endoscopic mapping of renal papillae for Randall's plaques in patients with urinary stone disease. J Urol 1997; 158: 2062-2064
32. Evan AE, Lingeman JE, Coe FL et al. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int 2008; 74: 223-229
33. Worcester EM, Gillen DL, Evan AP et al. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Ren Physiol 2007; 292: F66-F75
34. Worcester EM, Coe FL, Evan AP et al. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Ren Physiol 2008; 295: F1286-F1294
35. NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 1991; 114: 593-597
36. Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009; 94: 335-339
37. Mollerup CL, Lindewald H. Renal stones and primary hyperparathyroidism: natural history of renal stone disease after successful parathyroidectomy. World J Surg 1999; 23: 173-176
38. Rubin MR, Bilezikian JP, McMahon DJ et al. The natural history of primary hyperparathyroidism with and without parathyroid surgery after 15 years. J Clin Endocrinol Metab 2008; 93: 3462-3470
39. Frokjaer VG, Mollerup CL. Primary hyperparathyroidism: renal calcium excretion in patients with and without renal stone disease before and after parathyroidectomy. World J Surg 2002; 26: 532-535